+1 915 229 3004 (U.S.) | 
+44 7452 242832 (U.K.)
+1 915 229 3004 (U.S.) | +44 7452 242832 (U.K.)
Table of Contents
1. Executive summary
2. Market Introduction
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. Research Methodology
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Modality
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. Market Dynamics
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. Market Factor Analysis
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL Competent Cells MARKET,BY Type
6.1. Overview
6.2. Chemically Competent Cells
6.3. Electrocompetent Cells
7. GLOBAL Competent Cells MARKET,BY Application
7.1. Overview
7.2. Cloning
7.3. Protein Expression
7.4. Other Application
8. GLOBAL Competent Cells MARKET,BY End-use
8.1. Overview
8.2. Pharmaceutical and Biotechnology Companies
8.3. Academic Research Institutes
8.4. Contract Research Organizations (CROs)
8.5. Other End-users
9. GLOBAL Competent Cells MARKET, by Region
9.1. Overview
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe
9.4. Asia-Pacific
9.4.1. China
9.4.2. India
9.4.3. Japan
9.4.4. South Korea
9.4.5. Australia
9.4.6. Rest of Asia-Pacific
9.5. Rest of the World
9.5.1. Middle East
9.5.2. Africa
9.5.3. Latin America
10. Competitive Landscape
10.1. Overview
10.2. Competitive Analysis
10.3. Market Share Analysis
10.4. Major Growth Strategy in the Global Competent Cells Market,
10.5. Competitive Benchmarking
10.6. Leading Players in Terms of Number of Developments in the Global Competent Cells Market,
10.7. Key developments and Growth Strategies
10.7.1. New TypeLaunch/Application Deployment
10.7.2. Merger &Acquisitions
10.7.3. Joint Ventures
10.8. Major Players Financial Matrix
10.8.1. Sales & Operating Income,2022
10.8.2. Major Players R&D Expenditure.2022
11. Company ProfileS
11.1. Thermo Fisher Scientific
11.1.1. Company Overview
11.1.2. Financial Overview
11.1.3. Types Offered
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. Merck KGaA
11.2.1. Company Overview
11.2.2. Financial Overview
11.2.3. Types Offered
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. Agilent Technologies, Inc.
11.3.1. Company Overview
11.3.2. Financial Overview
11.3.3. Types Offered
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. Takara Bio Inc.
11.4.1. Company Overview
11.4.2. Financial Overview
11.4.3. Types Offered
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. New England Biolabs (UK) Ltd.
11.5.1. Company Overview
11.5.2. Financial Overview
11.5.3. Types Offered
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. HIMEDIA LABORATORIES
11.6.1. Company Overview
11.6.2. Financial Overview
11.6.3. Types Offered
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. Zymo Research
11.7.1. Company Overview
11.7.2. Financial Overview
11.7.3. Types Offered
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. Avantor
11.8.1. Company Overview
11.8.2. Financial Overview
11.8.3. Types Offered
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. TransGen Biotech Co., Ltd
11.9.1. Company Overview
11.9.2. Financial Overview
11.9.3. Types Offered
11.9.4. Key Developments
11.9.5. SWOT Analysis
11.9.6. Key Strategies
11.10. Scarab Genomics
11.10.1. Company Overview
11.10.2. Financial Overview
11.10.3. Types Offered
11.10.4. Key Developments
11.10.5. SWOT Analysis
11.10.6. Key Strategies
12. Appendix
12.1. References
12.2. Related Reports
LIST OF TABLES
TABLE 1 Global Competent Cells Market, Synopsis, 2018-2032
TABLE 2 Global Competent Cells Market, Estimates &Forecast, 2018-2032(USD BILLION)
TABLE 3 GLOBAL Competent Cells MARKET,BY Type, 2018-2032 (USD BILLION)
TABLE 4 GLOBAL Competent Cells MARKET,BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 5 GLOBAL Competent Cells MARKET,BY END-USE, 2018-2032 (USD BILLION)
TABLE 6 North AmericaCompetent Cells MARKET,BY Type, 2018-2032 (USD BILLION)
TABLE 7 North AmericaCompetent Cells MARKET,BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 8 North AmericaCompetent Cells MARKET,BY END-USE, 2018-2032 (USD BILLION)
TABLE 9 North America Competent Cells MARKET,BY Country, 2018-2032 (USD BILLION)
TABLE 10 U.S. Competent Cells MARKET,BY Type, 2018-2032 (USD BILLION)
TABLE 11 U.S. Competent Cells MARKET,BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 12 U.S. Competent Cells MARKET,BY END-USE, 2018-2032 (USD BILLION)
TABLE 13 Canada Competent Cells MARKET,BY Type, 2018-2032 (USD BILLION)
TABLE 14 Canada Competent Cells MARKET,BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 15 Canada Competent Cells MARKET,BY END-USE, 2018-2032 (USD BILLION)
TABLE 16 Europe Competent Cells MARKET,BY Type, 2018-2032 (USD BILLION)
TABLE 17 Europe Competent Cells MARKET,BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 18 Europe Competent Cells MARKET,BY END-USE, 2018-2032 (USD BILLION)
TABLE 19 Europe Competent Cells MARKET,BY Country, 2018-2032 (USD BILLION)
TABLE 20 Germany Competent Cells MARKET,BY Type, 2018-2032 (USD BILLION)
TABLE 21 Germany Competent Cells MARKET,BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 22 Germany Competent Cells MARKET,BY END-USE, 2018-2032 (USD BILLION)
TABLE 23 France Competent Cells MARKET,BY Type, 2018-2032 (USD BILLION)
TABLE 24 France Competent Cells MARKET,BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 25 France Competent Cells MARKET,BY END-USE, 2018-2032 (USD BILLION)
TABLE 26 Italy Competent Cells MARKET,BY Type, 2018-2032 (USD BILLION)
TABLE 27 Italy Competent Cells MARKET,BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 28 Italy Competent Cells MARKET,BY END-USE, 2018-2032 (USD BILLION)
TABLE 29 Spain Competent Cells MARKET,BY Type, 2018-2032 (USD BILLION)
TABLE 30 Spain Competent Cells MARKET,BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 31 Spain Competent Cells MARKET,BY END-USE, 2018-2032 (USD BILLION)
TABLE 32 U.K Competent Cells MARKET,BY Type, 2018-2032 (USD BILLION)
TABLE 33 U.K Competent Cells MARKET,BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 34 U.K Competent Cells MARKET,BY END-USE, 2018-2032 (USD BILLION)
TABLE 35 Rest of Europe Competent Cells MARKET,BY Type, 2018-2032 (USD BILLION)
TABLE 36 Rest of Europe Competent Cells MARKET,BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 37 Rest of Europe Competent Cells MARKET,BY END-USE, 2018-2032 (USD BILLION)
TABLE 38 Asia Pacific Competent Cells MARKET,BY Type, 2018-2032 (USD BILLION)
TABLE 39 Asia Pacific Competent Cells MARKET,BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 40 Asia Pacific Competent Cells MARKET,BY END-USE, 2018-2032 (USD BILLION)
TABLE 41 Asia Pacific Competent Cells MARKET,BY Country, 2018-2032 (USD BILLION)
TABLE 42 Japan Competent Cells MARKET,BY Type, 2018-2032 (USD BILLION)
TABLE 43 Japan Competent Cells MARKET,BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 44 Japan Competent Cells MARKET,BY END-USE, 2018-2032 (USD BILLION)
TABLE 45 China Competent Cells MARKET,BY Type, 2018-2032 (USD BILLION)
TABLE 46 China Competent Cells MARKET,BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 47 China Competent Cells MARKET,BY END-USE, 2018-2032 (USD BILLION)
TABLE 48 India Competent Cells MARKET,BY Type, 2018-2032 (USD BILLION)
TABLE 49 India Competent Cells MARKET,BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 50 India Competent Cells MARKET,BY END-USE, 2018-2032 (USD BILLION)
TABLE 51 Australia Competent Cells MARKET,BY Type, 2018-2032 (USD BILLION)
TABLE 52 Australia Competent Cells MARKET,BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 53 Australia Competent Cells MARKET,BY END-USE, 2018-2032 (USD BILLION)
TABLE 54 south korea Competent Cells MARKET,BY Type, 2018-2032 (USD BILLION)
TABLE 55 south korea Competent Cells MARKET,BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 56 south korea Competent Cells MARKET,BY END-USE, 2018-2032 (USD BILLION)
TABLE 57 Rest of asia-pacific Competent Cells MARKET,BY Type, 2018-2032 (USD BILLION)
TABLE 58 Rest of asia-pacific Competent Cells MARKET,BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 59 Rest of asia-pacific Competent Cells MARKET,BY END-USE, 2018-2032 (USD BILLION)
TABLE 60 Rest of WOrld Competent Cells MARKET,BY Type, 2018-2032 (USD BILLION)
TABLE 61 Rest of WOrldCompetent Cells MARKET,BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 62 Rest of WOrldCompetent Cells MARKET,BY END-USE, 2018-2032 (USD BILLION)
TABLE 63 Rest of WOrldCompetent Cells MARKET,BY Country, 2018-2032 (USD BILLION)
TABLE 64 Middle east Competent Cells MARKET,BY Type, 2018-2032 (USD BILLION)
TABLE 65 Middle east Competent Cells MARKET,BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 66 Middle east Competent Cells MARKET,BY END-USE, 2018-2032 (USD BILLION)
TABLE 67 Africa Competent Cells MARKET,BY Type, 2018-2032 (USD BILLION)
TABLE 68 Africa Competent Cells MARKET,BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 69 Africa Competent Cells MARKET,BY END-USE, 2018-2032 (USD BILLION)
TABLE 70 Latin america Competent Cells MARKET,BY Type, 2018-2032 (USD BILLION)
TABLE 71 Latin america Competent Cells MARKET,BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 72 Latin america Competent Cells MARKET,BY END-USE, 2018-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 Research Process
FIGURE 2 Market Structure for the Global Competent Cells Market
FIGURE 3 Market Dynamics for the Global Competent Cells Market
FIGURE 4 Global Competent Cells Market, Share (%), BY Type, 2022
FIGURE 5 Global Competent Cells Market, Share (%), BY APPLICATION, 2022
FIGURE 6 Global Competent Cells Market, Share (%), BY END-USE, 2022
FIGURE 7 Global Competent Cells Market, Share (%), by Region, 2022
FIGURE 8 north AMERICA: Competent Cells MARKET, SHARE (%), BY REGION, 2022
FIGURE 9 Europe: Competent Cells MARKET, SHARE (%), BY REGION, 2022
FIGURE 10 Asia-Pacific: Competent Cells MARKET, SHARE (%), BY REGION, 2022
FIGURE 11 Rest of the world: Competent Cells MARKET, SHARE (%), BY REGION, 2022
FIGURE 12 Global Competent Cells Market: Company Share Analysis, 2022 (%)
FIGURE 13 Thermo Fisher Scientific: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 14 Thermo Fisher Scientific: SWOT ANALYSIS
FIGURE 15 Merck KGaA:FINANCIAL OVERVIEW SNAPSHOT
FIGURE 16 Merck KGaA:SWOT ANALYSIS
FIGURE 17 Agilent Technologies, Inc.:FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 Agilent Technologies, Inc.:SWOT ANALYSIS
FIGURE 19 Takara Bio Inc.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 Takara Bio Inc.:SWOT ANALYSIS
FIGURE 21 New England Biolabs (UK) Ltd..:FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 New England Biolabs (UK) Ltd..:SWOT ANALYSIS
FIGURE 23 HIMEDIA LABORATORIES:FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 HIMEDIA LABORATORIES:SWOT ANALYSIS
FIGURE 25 Zymo Research: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 Zymo Research: SWOT ANALYSIS
FIGURE 27 Avantor: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 Avantor: SWOT ANALYSIS
FIGURE 29 TransGen Biotech Co., Ltd: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 TransGen Biotech Co., Ltd: SWOT ANALYSIS
FIGURE 31 Scarab Genomics: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 Scarab Genomics: SWOT ANALYSIS
Report Code :
RL65117
Published on :
Aug 2023
Request a Free Sample Report
Speak to Analyst